CeriBell Inc (CBLL)

Currency in USD
21.31
+2.01(+10.41%)
Closed·
21.49+0.18(+0.84%)
·
Advertisement
Unusual trading volume
CBLL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
18.6521.75
52 wk Range
10.8524.33
Key Statistics
Prev. Close
21.31
Open
20.01
Day's Range
18.65-21.75
52 wk Range
10.85-24.33
Volume
1.86M
Average Volume (3m)
389.26K
1-Year Change
82.1368%
Book Value / Share
3.74
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CBLL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
27.00
Upside
+26.70%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

CeriBell Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

8 Buy
0 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 27.00
(+26.70% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Canaccord
Buy25.00+17.32%28.00Maintain12/05/2026
TD Cowen
Buy29.00+36.09%-Maintain15/04/2026
Canaccord Genuity
Buy30.00+40.78%29.00Maintain17/12/2025
BTIG
Buy30.00+40.78%-Maintain15/12/2025
Raymond James
Buy26.00+22.01%19.00Maintain09/12/2025

CeriBell Inc Earnings Call Summary for Q2/2026

  • Q2 revenue rose 33% YoY to $28.1M with record 92% gross margin; raised FY2026 guidance to $114M-$117M from $112M-$116M prior range.
  • Posted $0.51/share loss vs. $0.36 consensus, driven by higher operating expenses; stock gained 2.61% in regular trading despite 41.7% EPS miss.
  • Active accounts grew to 712, up 32 sequentially; management sees expansion opportunity as top accounts utilize product 3x more than average peers.
  • Delirium monitoring launching Q4 2026 with CMS reimbursement; new hardware platform with video/ECG features targeted for 2027 commercial release.
  • Refinanced credit facility post-quarter for up to $60M committed capital; aims to maintain ~$10M adjusted EBITDA losses while scaling operations.
Last Updated: 10/08/2026, 22:32
Read Full Transcript

Earnings

Latest Release
10/08/2026
EPS / Forecast
-0.51 / -0.36
Revenue / Forecast
28.1M / --
EPS Revisions
Last 90 days

Compare CBLL to Peers and Sector

Metrics to compare
CBLL
Peers
Sector
Relationship
P/E Ratio
−12.3x1.4x−0.4x
PEG Ratio
−4.440.010.00
Price/Book
6.3x1.8x2.6x
Price / LTM Sales
8.0x1.6x3.1x
Upside (Analyst Target)
22.0%9.1%47.5%
Fair Value Upside
Unlock12.9%5.9%Unlock

CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm. In addition, it operates an EEG portal, which enables real-time remote access to a patient’s EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
10.69M28.18%206.39M
Other Institutional Investors
36.39M71.82%702.29M
Public Companies & Retail Investors
0.000.00%0.00
Total
47.08M100.00%908.68M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
FMR LLC15.00%5,690,773109,832
TPG Capital, L.P.9.92%3,765,05472,666

People Also Watch

23.75
AKOa
+3.26%
39.76
TRS
-0.60%
49.46
ATMU
-0.32%
31.59
ATLO
+1.87%
327.53
SXI
-0.19%

FAQ

What Is the CeriBell (NASDAQ: CBLL) Share Price Today?

The CeriBell stock price today is 21.31 USD.

What Stock Exchange Does CeriBell (CBLL) Trade On?

CeriBell is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for CeriBell?

The stock symbol (also called a 'ticker') for CeriBell is "CBLL."

What Is the Current CeriBell Market Capitalisation?

As of today, CeriBell (NASDAQ: CBLL) market cap is 814.54M USD.

What Is CeriBell's (CBLL) Earnings Per Share (TTM)?

The CeriBell EPS is currently -1.76 (Trailing Twelve Months).

When Is the Next CeriBell Earnings Date?

CeriBell's next earnings report will be released on 10/08/2026.

Is CBLL a Buy or Sell From a Technical Analyst Perspective?

Based on today's CeriBell moving averages and other technical indicators, the daily buy/sell signal for CBLL stock is Strong Buy.

How Many Times Has CeriBell Stock Split?

CeriBell has split 0 times. (See the CBLL stock split history page for full effective split date and price information.)

How Many Employees Does CeriBell Have?

CeriBell has 327 employees, based on their latest Companies House report.

What is the current trading status of CeriBell (NASDAQ: CBLL)?

As of 12/08/2026, CeriBell (CBLL) is trading at a share price of 21.31 USD, with a previous close of 21.31 USD. The stock has fluctuated within a day range of 18.65 USD to 21.75 USD, while its 52-week range spans from 10.85 USD to 24.33 USD.

What Is CeriBell (CBLL) Price Target According to Analysts?

The average 12-month price target for CeriBell is 27.00 USD, with a high estimate of 32 USD and a low estimate of 24 USD. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +26.70% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.